399 related articles for article (PubMed ID: 14532804)
1. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
[TBL] [Abstract][Full Text] [Related]
2. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
[TBL] [Abstract][Full Text] [Related]
3. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.
Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U
Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260
[TBL] [Abstract][Full Text] [Related]
4. Medium-term experience of sacral neuromodulation by tined lead implantation.
Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
[TBL] [Abstract][Full Text] [Related]
5. Canadian experience in sacral neuromodulation.
Elkelini M; Hassouna MM
Urol Clin North Am; 2005 Feb; 32(1):41-9. PubMed ID: 15698875
[TBL] [Abstract][Full Text] [Related]
6. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence.
Shaker HS; Hassouna M
J Urol; 1998 May; 159(5):1516-9. PubMed ID: 9554345
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
8. Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women.
Borawski KM; Foster RT; Webster GD; Amundsen CL
Neurourol Urodyn; 2007; 26(1):14-8. PubMed ID: 17123297
[TBL] [Abstract][Full Text] [Related]
9. New screening technique for sacral nerve stimulation under local anaesthesia.
Hetzer FH; Hahnloser D; Knoblauch Y; Löhlein F; Demartines N
Tech Coloproctol; 2005 Apr; 9(1):25-8. PubMed ID: 15868495
[TBL] [Abstract][Full Text] [Related]
10. [Continuous bilateral sacral neuromodulation as a minimally invasive implantation technique in patients with functional bladder changes].
Martín Braun P; Arancibia Fernández MI; Martínez Portillo FJ; Seif C; Sotelino Crespo A; Sugimoto S; de Dios Montoto E; Alken P; Jünemann KP
Arch Esp Urol; 2003 Jun; 56(5):497-501. PubMed ID: 12918307
[TBL] [Abstract][Full Text] [Related]
11. Failure of sacral nerve stimulation due to migration of tined lead.
Deng DY; Gulati M; Rutman M; Raz S; Rodríguez LV
J Urol; 2006 Jun; 175(6):2182-5. PubMed ID: 16697835
[TBL] [Abstract][Full Text] [Related]
12. [Use of permanent electrodes in the peripheral nerve evaluation test (PNE-Test) in comparison to conventional wire electrodes].
Seif C; Bannowsky A; Wefer B; Naumann VC; van der Horst C; Jünemann KP; Braun PM
Aktuelle Urol; 2006 Jul; 37(4):277-80. PubMed ID: 16878281
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.
Chartier-Kastler EJ; Ruud Bosch JL; Perrigot M; Chancellor MB; Richard F; Denys P
J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686
[TBL] [Abstract][Full Text] [Related]
14. Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator.
Groen J; Amiel C; Bosch JL
Neurourol Urodyn; 2005; 24(3):226-30. PubMed ID: 15825153
[TBL] [Abstract][Full Text] [Related]
15. Sacral neuromodulation for refractory detrusor overactivity in women with an artificial urinary sphincter.
Roupret M; Chartier-Kastler E; Almeras C; Ayoub N; Haertig A; Richard F
J Urol; 2004 Jul; 172(1):236-9. PubMed ID: 15201782
[TBL] [Abstract][Full Text] [Related]
16. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
17. Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.
Pham K; Guralnick ML; O'Connor RC
Neurourol Urodyn; 2008; 27(8):779-81. PubMed ID: 18551562
[TBL] [Abstract][Full Text] [Related]
18. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
19. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
Daniels DH; Powell CR; Braasch MR; Kreder KJ
Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
[TBL] [Abstract][Full Text] [Related]
20. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?
Kessler TM; Madersbacher H; Kiss G
Eur Urol; 2005 May; 47(5):660-5. PubMed ID: 15826759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
